Sleep well. Wherever you are.
iNAP® (intraoral Negative Air Pressure)
Sleep Therapy System
Obstructive Sleep Apnea
Are you or your relatives experienced
<Daytime>
Hypersomnia, lack of concentration
Lost of Memory, Depression
<Nighttime>
Insomnia, Nocturia, Sleep disruption
<during Sleep>
Snoring, experience of Sleep Apnea
Choking, Gasping for air
If so, you might likely be suffering from
Obstructive Sleep Apnea,
also known as OSA
iNAP® Sleep Therapy System
A Great Sleep experience for patients to get high-quality and uninterrupted sleep every night
Do I have
Sleep Apnea?
Epworth Sleepiness Scale
The higher the score,
the higher the risk of suffering
Obstructive Sleep Apnea (OSA).
iNAP® One
F E A T U R E
-
Natural Breathing
-
Battery-Powered
-
Discreet and Quiet
-
Operation Without Mask
-
Excellent Wearing Comfort
-
Portable and Travel-Friendly
PATIENT OUTCOMES
75.0%
66.5%
72.6%
Response Rate
30.2%
Reduction in ODI
Reduction in AHI
5.5%
Reduction in Arousal Index
Increase in Lowest SpO2
GLOBAL RECOGNITIONS
2020
-
RESI Innovation Challenge First Price
2019
European Product Design Awards - Silver
-
European Product Design Awards, Silver
-
Asian Science Park Association ASPA Award, Grand Prize
-
Hsinchu Science Park Innovative Product Award, Taiwan
2017
-
25th Taiwan Excellence Award, Taiwan
-
45th Salon International Des Invention, Geneva: Gold (iNAP One); Silver (iNAP Lite)
2016
-
iF Design Award, Germany
-
A’ Design Award, Italy
-
ERS Point Award, UK
-
Hsinchu Science Park Innovative Product Award, Taiwan
-
Taipei Biotech Awards, Innovation Silver Medal Award, Taiwan
-
Biotech Industries Innovation & Excellence Silver Award, Taiwan
-
National Invention Award, Taiwan
-
13th National Innovation Award, Taiwan
A novel intermittent negative air pressure device ameliorates obstructive sleep apnea syndrome in adults.
The article is co-authored by Prof. Christian Guilleminault of Standard University.
Thirty-five patients were enrolled: age 41.9 ± 12.2 years (mean ± standard deviation), BMI 26.6 ± 4.3 kg/m2, AHI 41.4 ± 24.3 events/hour, and oxygen-desaturation-index (ODI) 40.9 ± 24.4 events/hour at baseline. AHI and ODI were significantly decreased (p<0.001) by the device. Patients with moderate OSAS, with baseline AHI between 15 to 30 events/hour, achieved 64% response rate; and non-obese patients, with BMI below 25 kg/m2, achieved 57% response rate, with response rate defined as 50% reduction in AHI from baseline and treated AHI lower than 20.
Keywords Obstructive sleep apnea syndrome . Sleep-disordered breathing . Apnea–hypopnea index . Intermittent negative air pressure . Intraoral device . Oral pressure therapy
BUY IT NOW
Worldwide Distributors
ผู้จัดจำหน่ายในประเทศไทย
